ASLAN Pharmaceuticals (ASLN)
(Delayed Data from NSDQ)
$0.41 USD
-0.01 (-1.22%)
Updated May 13, 2024 04:00 PM ET
After-Market: $0.40 -0.01 (-1.48%) 5:24 PM ET
2-Buy of 5 2
F Value A Growth C Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/9/24 |
---|---|
Current Quarter | -0.52 |
EPS Last Quarter | -1.29 |
Last EPS Surprise | -89.71% |
ABR | 1.00 |
Earnings ESP
|
-3.85% |
---|---|
Current Year | -2.69 |
Next Year | -2.42 |
EPS (TTM) | -2.74 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 12.00M | 0.00M | 12.00M | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.52 | -0.52 | -2.69 | -2.42 |
# of Estimates | 2 | 2 | 2 | 1 |
Most Recent Consensus | NA | NA | NA | NA |
High Estimate | -0.50 | -0.50 | -1.75 | -2.42 |
Low Estimate | -0.54 | -0.53 | -3.62 | -2.42 |
Year ago EPS | -0.11 | -0.56 | -2.69 | -2.69 |
Year over Year Growth Est. | -372.73% | 7.14% | 0.00% | 9.85% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 1 | 2 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 0 | 1 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.52 | -0.52 | -2.69 | -2.42 |
7 Days Ago | -0.52 | -0.52 | -2.69 | -2.42 |
30 Days Ago | -0.52 | -0.52 | -2.62 | NA |
60 Days Ago | -0.59 | -0.59 | -3.25 | NA |
90 Days Ago | -0.59 | -0.59 | -3.25 | NA |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.54 | -0.52 | -3.62 | -2.42 |
Zacks Consensus Estimate | -0.52 | -0.52 | -2.69 | -2.42 |
Earnings ESP | -3.85% | 0.00% | -34.82% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.29 | -0.78 | -0.56 | -0.11 | NA |
Estimate | -0.68 | NA | -0.85 | -0.87 | NA |
Difference | -0.61 | NA | 0.29 | 0.76 | 0.15 |
Surprise | -89.71% | NA | 34.12% | 87.36% | 10.59% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more